A recently published study in Journal of Neuroinflammation reports the finding that neurotensin (NT) is elevated in the serum of young children with autistic disorder \[[@B1]\]. In cultured rat cortical neurons, NT has been shown to increase glutamate outflow and to intensify N-methyl D-aspartic acid- (NMDA-) mediated glutamate signaling \[[@B2]\]. In addition, NT may enhance glutamate transmission and, in particular, activate NMDA receptors \[[@B3],[@B4]\]. Such overstimulation of NMDA glutamate receptors can lead to excitotoxicity \[[@B5]\]. Thus, factors that modulate glutamatergic transmission may affect glutamate-induced cell apoptosis.

Previous studies have suggested a possible role for a hyperglutaminergic state in autism \[[@B6]\]. Further, an antagonist of the NMDA glutamate receptor, memantine, has been shown to improve some symptoms in autism \[[@B7]\]. In contrast, there have been conflicting reports regarding the effects of NT on GABAergic synapses. At least one study has reported that NT inhibits GABAergic synaptic transmission in rats \[[@B8]\]. Other studies have indicated that NT enhances GABA release \[[@B9]\], activates GABAergic interneurons in rat prefrontal cortex \[[@B10]\], and increases GABAergic activity in rat hippocampus \[[@B11]\]. NT may act in the CNS as an atypical neuroleptic \[[@B12]\]. Studies using an antagonist of the NT receptor subtype 1 (NTS1) have elucidated the functions driven by this receptor \[[@B13]\], and antagonism of NTS1 has been suggested as a novel therapeutic approach for the treatment of Parkinson\'s disease \[[@B4]\].

The higher serum levels of NT in young patients with autistic disorder does not necessarily indicate a casual role in autism \[[@B1]\]. Elevated NT levels in autistic disorder could be a result of inflammation. However, considering the known imbalance in glutamate-to-GABA ratios in children with autism \[[@B14]\], the higher levels of glutamate in autism \[[@B14]\], the downregulation of GABA(A) receptors in autism \[[@B15]\], and the role of NT in excessive activation of the NMDA receptor and apoptosis \[[@B3],[@B4]\], NT may mediate brain damage in addition to activating inflammatory processes in autism. These observations collectively suggest a hypothesis that modulation of NT or of its receptors, in combination with traditional drugs, may provide a novel approach for the management of autism.
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